Corporate Advisory Board
Not unlike our Medical Advisory Board, our Corporate Advisory Board is replete with some of the top business minds in the healthcare industry. Loaded with experience and savvy, Our Corporate Advisory Board serves as the gateway to ensure that we can continue to work towards our vision and help those affected by cancer.


Daniel J. Arbess
Founder, CEO,
Chief Investment Officer,
Xerion Investments
Chief Investment Officer,
Xerion Investments


Andrew Cone
Chief Revenue Officer,
MultiPlan
MultiPlan


Sujay Kango
CCO,
Acceleron Pharma
Acceleron Pharma


Tom Langan
CEO,
Veradigm
Veradigm


Steve Mackin
SVP, Mercy Health &
President, Mercy Hospital
St. Louis
President, Mercy Hospital
St. Louis


David Shulkin
Former US Secretary
of Veterans Affairs
of Veterans Affairs


Steve Simcox
CEO,
Healthtalker
Healthtalker


Doug Ulman
CEO, Pelotonia,
Former CEO of Livestrong
Former CEO of Livestrong


Douglas Watson
Former Chairman of Dendreon,
Former US CEO of Novartis
Former US CEO of Novartis


Peter Wentworth
HR Consultant